1W Return
1M Return
6M Return
1Y Return
3Y Return
Start SIP in Medi Caps
Medi Caps Stock Performance
52 Week Low - High
Today’s Low - High
Open
Prev. Close
Total Traded Value
Medi Caps Fundamental
Market Cap (in crs)
Face Value
Turnover (in lacs)
Key Metrics
Qtr Change %
Near 52W Low of ₹41.00
-14.7
Dividend yield 1yr %
0
Medi Caps Key Financials
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Medi Caps Quarterly Revenue
| Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|
4.02 Cr | 8.3 Cr | 6.19 Cr | 7.87 Cr | 7.07 Cr |
Medi Caps Yearly Revenue
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|
27.82 Cr | 50.97 Cr | 71.79 Cr | 59.3 Cr | 45.92 Cr | 54.51 Cr |
Medi Caps Quarterly Net Profit/Loss
| Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|
-2.04 Cr | 0.31 Cr | -0.56 Cr | -1.08 Cr | -0.16 Cr |
Medi Caps Yearly Net Profit/Loss
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|
-2.24 Cr | 1.87 Cr | 10.04 Cr | 11.24 Cr | -5.85 Cr | 5.39 Cr |
Medi Caps Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
Current Price
5Day EMA
42.80
10Day EMA
43.20
12Day EMA
43.30
20Day EMA
43.70
26Day EMA
43.90
50Day EMA
45.10
100Day EMA
46.80
200Day EMA
48.00
5Day SMA
43.00
10Day SMA
43.40
20Day SMA
43.40
30Day SMA
44.10
50Day SMA
44.80
100Day SMA
47.70
150Day SMA
49.00
200Day SMA
49.30
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 3949 Rs | 4251 Rs |
Week Rs | 4525 Rs | 5237 Rs |
Month Rs | 2645 Rs | 3401 Rs |
Resistance & Support
42.33
Pivot
Resistance
First Resistance
42.91
Second Resistance
43.86
Third Resistance
44.44
Support
First Support
41.38
Second support
40.80
Third Support
39.85
Relative Strength Index
38.24
Money Flow Index
26.12
MACD
-0.65
MACD Signal
-0.60
Average True Range
2.49
Average Directional Index
13.04
Rate of Change (21)
-8.54
Rate of Change (125)
-24.87
Similar stocks
Similar Stocks
Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
52.32 | 41 | 61 | 42.01 | -2.92% | 1.08% | -21.77% | -19.48% | -23.57% | 0.00% | 104.90 | 48.66 | 0.77 | ||
Sandu Pharmaceuticals Ltd. | 51.72 | - | - | - | - | - | - | - | - | - | - | - | - | |
Godavari Drugs Ltd. | 90.14 | - | - | - | - | - | - | - | - | - | - | - | - | |
Vista Pharmaceuticals Ltd. | 10.86 | - | - | - | - | - | - | - | - | - | - | - | - | |
Chandra Bhagat Pharma Ltd. | 60.00 | - | - | - | - | - | - | - | - | - | - | - | - | |
JFL Life Sciences Ltd. | 19.70 | - | - | - | - | - | - | - | - | - | - | - | - | |
Dipna Pharmachem Ltd. | 21.42 | - | - | - | - | - | - | - | - | - | - | - | - |
Medi Caps Company background
Founded in: 1983
Managing director: Alok K Garg
Medicaps was incorporated by S L Mittal in Aug.83 as a private limited company and was converted into a public limited company in Mar.86. Pharmaceutical companies procure empty hard gelatine capsules from Medicaps for dosaged medicines meant for oral administration. The company is the secondlargest manufacturer of empty hard gelatine capsules in India. It takes several years for a company manufacturing capsules to attain zerodefect in production and to fully normalise operations. Medicaps can claim to have achieved this. In Apr.95, the company offered 6.11 lac rights shares at a premium of Rs 116 to partfinance the Rs 9.19cr expansion of its manufacturing facilities (from 2000 mln pa to 3440 mln pa) by installing four highspeed automatic capsulemaking machines.The companys manufacturing unit is located in Pithampur, Madhya Pradesh. The companys clientele include US Vitamins, SOL Pharmaceuticals, Dr Reddys Laboratories, Lupin Laboratories, Aristo Pharmaceuticals, etc. At present, it has 40 clients. The other group company of Medicaps is Medicaps Finance which is engaged in finance related activities. In 1993, R C Mittal received the Glory of India International award. In 199596, the company enhanced the capacity of empty hard gelatine capsules by 2500 lac. The company received ISO 9002 Certification during 199899. It developed six sizes of the Hard Gelatin Capsules in 200203. The company is closely working on commissioning of 13th Machine with 100% automisation. During 200203 the company established the export market in countries like China,Thailand,Dubai,Malaysia,South Africa and Philipines.The Company permanently discontinued its manufacturing activities on 21.11.2019 at the plant in Pithampur, Dhar Dist. and ventured into Real Estate Business and in continuation of this, it executed an agreement with the Tirupati Reality Developers on 12 October, 2020 for Project named Medicaps Business Park.
Medi Caps FAQs
How has Medi Caps shares performed in the past ?
Medi Caps share price in the past 1-year return was -19.47. The Medi Caps share hit a 1-year low of Rs. 41 and a 1-year high of Rs. 61.
What is the market cap of Medi Caps ?
The market cap of Medi Caps is Rs. 52.32 Cr. as of 29/4/2025.
What is the current P/E ratio of Medi Caps ?
The PE ratios of Medi Caps is 104.9 as of 29/4/2025.
What is the current PB ratio of Medi Caps ?
The PB ratios of Medi Caps is 0.77 as of 29/4/2025
What is the Mutual Fund shareholding in Medi Caps ?
The Mutual Fund Shareholding in Medi Caps was 0.01% at the end of 29/4/2025.
How to buy Medi Caps shares?
You can easily buy Medi Caps shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that Medi Caps stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account
